AS321 - Gentoxic estrogen ratio: a novel estrogen biomarker and breast cancer risk
Data Dictionaries and Study Documentation
This section displays all study-related data dictionaries and study-related files. The investigators for this study will upload the datasets, data dictionaries, and other study-related files. Study-related files will be made available to the public one year after the completion of the ancillary study, with the exception of the datasets, which will only be available to those with a Data Distribution Agreement. Those will be available to those with permission to download and will appear as a download link next to the data dictionary
Data Dictionaries
Name | Description |
|---|
Study Documents
Name | Description |
|---|---|
| NameAS321casecontrolsummary_20131209.docx | Description |
Related Papers
Risk of breast cancer associated with estrogen DNA adduct biomarker
Background: It is biologically plausible that genotoxic estrogens, namely estrogen DNA adducts (EDA), have a role in breast cancer development. Support comes from three prior studies that reported elevated concentrations of EDA relative to estrogen metabolites and conjugates (EDA:EMC) in women with breast cancer relative to control women. Methods: In postmenopausal women in the Women's Health Initiative (WHI), EDA:EMC in 191 controls was compared with findings in 194 prediagnosis urine samples f...
Keywords: Breast Cancer; Estrogens; Biomarker
Related Studies: 321
